Home
ADAR1 Capital Management reported a 13.27% stake in Keros Therapeutics KROS · 5,389,264 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 13.27%
- Last report
- 13.27% · filed 25/05/12
- Shares held
- 5,389,264 sh
- Class
- Common Stock, $0.0001 par value per share
- Holder
- ADAR1 Capital Management
- Event date
- 25/08/21
- Filed
- 25/08/21
13.27% stake · +0.0pp from the last report
- Stake
- 13.27%
- Last report
- 13.27%
- Since last report
- +0.0pp
Keros Therapeutics trades, last 26 weeks
What else happened in Keros Therapeutics around then
Filed or reported within 30 days of the trade day · 25/07/22~25/09/20ADAR1 Capital Management's other 5% stake reports
- ADAR1 Capital Management
5% stakeTenax Therapeutics
5% stakeTenax Therapeutics
TENX
14% stake
5,257,389 sh
14% stake
Filed 09/08
- ADAR1 Capital Management
5% stakeNextCure
5% stakeNextCure
NXTC
15.8% stake
722,419 sh
15.8% stake
Filed 08/14
- ADAR1 Capital Management
5% stakeYarrow Bioscience
5% stakeYarrow Bioscience
YARW
8.8% stake
59,000 sh
8.8% stake
Filed 08/14
- ADAR1 Capital Management
5% stakeRein Therapeutics
5% stakeRein Therapeutics
RNTX
5.3% stake
4,500,000 sh
5.3% stake
Filed 08/14
- ADAR1 Capital Management
5% stakeResearch Alliance Corp III
5% stakeResearch Alliance Corp III
RACC
8.4% stake
650,000 sh
8.4% stake
Filed 08/14
